PURPOSE The number of systemic anti-cancer therapy (SACT) regimens has expanded
rapidly over the last decade with the introduction of immunotherapy, small molecule targeted …

PURPOSE To better understand the barriers to accessing standard-of-care radiation therapy
(RT) for breast and cervical cancer in sub-Saharan Africa and their impact on outcomes …

In some countries of sub‐Saharan Africa, the prevalence of HIV exceeds 20%; in South
Africa, 20.4% of people are living with HIV. We examined the impact of HIV infection on the …

Introduction This study sought to compare the clinicopathologic features of women with
breast cancer presenting in South Africa, Botswana, and the United States (US). Methods …

Introduction Systemic treatment for breast cancer in sub-Saharan Africa (SSA) is cost
effective. However, there are limited real-world data on the translation of breast cancer …

The formidable impact of breast cancer extends globally, with South Africa facing
pronounced challenges, including significant disparities in breast cancer screening …

Purpose Among patients diagnosed with breast cancer (BC), women also living with HIV
(WLWH) have worse survival than women without HIV. Chronic HIV infection may interfere …

Abstract Introduction In the South African Breast Cancer and HIV Outcomes (SABCHO)
study, we previously found that breast cancer patients living with HIV and treated with …

PURPOSE High-quality histopathology reporting forms the basis for treatment decisions.
The quality indicator for pathology reports from the European Society of Breast Cancer …

PURPOSE Breast cancer (BC) is the most common female cancer worldwide, and the
burden is increasing across sub-Saharan Africa. For women with hormone receptor–positive …